These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Maintenance therapy and the natural course of schizophrenia. Davis JM J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):18-21. PubMed ID: 2865252 [TBL] [Abstract][Full Text] [Related]
4. New advances in pharmacotherapy for early psychosis. Emsley R Early Interv Psychiatry; 2009 Sep; 3 Suppl 1():S8-12. PubMed ID: 21352195 [TBL] [Abstract][Full Text] [Related]
5. [Maintenance therapy in schizophrenia -- a brief review of the literature]. Balla P; Frecska E Neuropsychopharmacol Hung; 2012 Sep; 14(3):197-200. PubMed ID: 22987733 [TBL] [Abstract][Full Text] [Related]
6. Relapse prevention and recovery in the treatment of schizophrenia. Schooler NR J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093 [TBL] [Abstract][Full Text] [Related]
7. [Continuity in the neuroleptic treatment in patients with schizophrenia. Current data]. Tignol J; Plagnol C; Auriacombe M; Cazenave M; O'Brien CP Ann Med Psychol (Paris); 1990 Mar; 148(3):290-3. PubMed ID: 1978624 [No Abstract] [Full Text] [Related]
8. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses. Turner MS; Stewart DW J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985 [TBL] [Abstract][Full Text] [Related]
9. Prevention of relapse in schizophrenia. Lieberman J; Stroup S; Schneider L N Engl J Med; 2002 May; 346(18):1412-3; author reply 1412-3. PubMed ID: 11987324 [No Abstract] [Full Text] [Related]
11. Management strategies for the treatment of schizophrenia. Kane JM J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604 [TBL] [Abstract][Full Text] [Related]
12. The natural course of schizophrenia and effective maintenance drug treatment. Davis JM; Andriukaitis S J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087 [TBL] [Abstract][Full Text] [Related]
13. Prevention of relapse in schizophrenia. Stalman SL N Engl J Med; 2002 May; 346(18):1412-3; author reply 1412-3. PubMed ID: 11987323 [No Abstract] [Full Text] [Related]
15. [Discontinuation of neuroleptic treatment in patients with schizophrenia]. Alagille M; Blondiaux I; Ginestet D Encephale; 1990; 16(2):125-31. PubMed ID: 1972052 [TBL] [Abstract][Full Text] [Related]
16. Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse? Gaebel W; Frick U; Köpcke W; Linden M; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J Br J Psychiatry Suppl; 1993 Sep; (21):8-12. PubMed ID: 8105814 [TBL] [Abstract][Full Text] [Related]
17. [To increase compliance-knowledge. Only every second schizophrenia patient remains faithful to the therapy]. MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579500 [No Abstract] [Full Text] [Related]
18. [The changing drug therapy of schizophrenia]. Koponen H Duodecim; 1997; 113(24):2617-22. PubMed ID: 10892175 [No Abstract] [Full Text] [Related]
19. Review of treatments that can ameliorate nonadherence in patients with schizophrenia. Kane JM J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091 [TBL] [Abstract][Full Text] [Related]